Multiple Myeloma Clinical Trials in New York

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
R
Recruiting
  • Multiple Myeloma
  • Miami, Florida
  • +14 more
2021-10-07
Oct 7, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
2021-10-14
Oct 14, 2021
A
Terminated
  • Multiple Myeloma
  • +6 more
  • AMG 397
  • +2 more
  • Birmingham, Alabama
  • +20 more
2021-10-08
Oct 8, 2021
J
Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +27 more
2021-10-07
Oct 7, 2021
S
Recruiting
  • Multiple Myeloma
  • Palo Alto, California
  • +10 more
2021-10-01
Oct 1, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Southington, Connecticut
  • +63 more
2021-10-07
Oct 7, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
2021-10-07
Oct 7, 2021
M
Recruiting
  • Lymphoma
  • +4 more
    • Basking Ridge, New Jersey
    • +5 more
    2021-10-07
    Oct 7, 2021
    J
    Recruiting
    • Multiple Myeloma
    • Carfilzomib 20 mg/m^2
    • +4 more
    • Gilbert, Arizona
    • +112 more
    2021-10-07
    Oct 7, 2021
    J
    Active, not recruiting
    • Multiple Myeloma
    • Little Rock, Arkansas
    • +56 more
    2021-10-07
    Oct 7, 2021
    A
    Recruiting
    • Advanced Solid Tumor
    • +9 more
    • Phoenix, Arizona
    • +19 more
    2021-10-06
    Oct 6, 2021
    A
    Active, not recruiting
    • Multiple Myeloma
    • AMG 224
    • West Hollywood, California
    • +4 more
    2021-09-09
    Sep 9, 2021
    P
    Active, not recruiting
    • Multiple Myeloma
    • Birmingham, Alabama
    • +45 more
    2021-10-06
    Oct 6, 2021